This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

Entecavir Induced Severe Myopathy: An Uncommon Side Effect

Volume: 2, Issue: 1, Pages: 15 - 17
Published: Apr 6, 2021
Abstract
Chronic Hepatitis B virus (HBV) infection is a chronic viral illness that affects millions of people around the world and can cause serious consequences such as hepatic failure and hepatocellular carcinoma.Entecavir, a guanosine nucleoside analog (NA), is a commonly used and generally safe therapeutic agent in HBV infection.In this paper, we aimed to present a case of chronic HBV that developed severe myopathy as an extremely rare side effect...
Paper Details
Title
Entecavir Induced Severe Myopathy: An Uncommon Side Effect
Published Date
Apr 6, 2021
Volume
2
Issue
1
Pages
15 - 17
References
No data available
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.